Efficacy and Safety of Mycophenolate Mofetil in Children with Steroid Dependent Nephrotic Syndrome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Steroid dependent nephrotic syndrome (SDNS) is a chronic illness in childhood hard to treat. Steroid sparing drugs are often used, because long-term steroid therapy can cause severe side effects. We studied to compare efficacy between MMF and other drugs including cyclosporine and levamisole. Methods: This study was performed retrospectively on patients with SDNS, who were treated at Pusan National University Children’s hospital. MMF group included 11 patients who were treated with MMF for at least six months between June 2012 and July 2014. As control groups, cyclosporine group (n=15) and levamisole group (n=18) included patients treated between January 2008 and July 2014. Number of relapse was analyzed in patients treated more than six months, and relapse free for one year was analyzed in patients treated more than one year. Results: In MMF group, ten were boys and mean age at onset was 5.8 years. Mean age at starting of MMF was 8.6 years. Number of relapse in MMF group was reduced significantly after treatment from 3.4 /year to 0.2 /year (P=0.003). There was no significant difference in number of relapse among groups (MMF: 0.2 /year, cyclosporine: 0.5 /year, levamisole: 0.5 /year). Comparing the early relapse within six months after treatment levamisole group was significantly higher than the other two groups (P=0.04). Conclusions: MMF which is used in SDNS significantly reduced the relapse and side effects were rare. In addition, MMF did not show any significant difference in comparison with the other two groups in number of relapse and relapse free for one year.
Abstract
Purpose: Steroid dependent nephrotic syndrome (SDNS) is a chronic illness in childhood hard to treat. Steroid sparing drugs are often used, because long-term steroid therapy can cause severe side effects. We studied to compare efficacy between MMF and other drugs including cyclosporine and levamisole. Methods: This study was performed retrospectively on patients with SDNS, who were treated at Pusan National University Children’s hospital. MMF group included 11 patients who were treated with MMF for at least six months between June 2012 and July 2014. As control groups, cyclosporine group (n=15) and levamisole group (n=18) included patients treated between January 2008 and July 2014. Number of relapse was analyzed in patients treated more than six months, and relapse free for one year was analyzed in patients treated more than one year. Results: In MMF group, ten were boys and mean age at onset was 5.8 years. Mean age at starting of MMF was 8.6 years. Number of relapse in MMF group was reduced significantly after treatment from 3.4 /year to 0.2 /year (P=0.003). There was no significant difference in number of relapse among groups (MMF: 0.2 /year, cyclosporine: 0.5 /year, levamisole: 0.5 /year). Comparing the early relapse within six months after treatment levamisole group was significantly higher than the other two groups (P=0.04). Conclusions: MMF which is used in SDNS significantly reduced the relapse and side effects were rare. In addition, MMF did not show any significant difference in comparison with the other two groups in number of relapse and relapse free for one year.
참고문헌 (35)
- "A report of the international study of kidney disease in children", Kidney Int, 20, pp.765~771 (1981)
- Cheong WY, "Recent advance in nephrotic syndrome", J Korean Soc Pediatr Nephrol, 6, pp.15~24 (2002)
- Siegel NJ, "Long-term follow-up of children with steroid-responsive nephrotic syndrome", J Pediatr, 81, pp.251~258 (1972)
- Hoyer PF, "Cyclosporin in frequently relapsing minimal change nephrotic syndrome", Lancet, 2, pp.335~ (1986)
- Tanphaichitr P, "Treatment of nephrotic syndrome with levamisole", J Pediatr, 96, pp.490~493 (1980)
- Moudgil A, "Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood : Current status and future directions", Pediatr Nephrol, 20, pp.1376~1381 (2005)
- Ponticelli C, "Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome : A multicentre randomized controlled trial", Nephrol Dial Transplant, 8, pp.1326~1332 (1993)
- Inoue Y, "Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome", Pediatr Nephrol, 13, pp.33~38 (1999)
- Cattran DC, "A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis", Kidney Int, 56, pp.2220~2226 (1999)
- Ishikura K, "Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome", Nephrol Dial Transplant, 25, pp.3956~3962 (2010)
- Tanaka R, "Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome", Pediatr Nephrol, 7, pp.249~252 (1993)
- Hino S, "Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine", Am J Kidney Dis, 31, pp.932~939 (1998)
- Fujinaga S, "Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome", Arch Dis Child, 91, pp.666~670 (2006)
- Iijima K, "Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome", Kidney Int, 61, pp.1801~1805 (2002)
- Nakamura T, "Association of cumulative cyclosporine dose with its irreversible nephrotoxicity in japanese patients with pediatriconset autoimmune diseases", Biol Pharm Bull, 30, pp.2371~2375 (2007)
- Sairam VK, "Secondary resistance to cyclosporin A in children with nephrotic syndrome", Pediatr Nephrol, 17, pp.842~846 (2002)
- Habashy D, "Interventions for idiopathic steroid-resistant nephrotic syndrome in children", Cochrane Database Syst Rev, (2), pp.CD003594~ (2004)
- Niaudet P, "Cyclosporin in the treatment of idiopathic nephrotic syndrome in children", Pediatr Nephrol, 1, pp.566~573 (1987)
- Han JH, "The effect of levamisole in steroid-dependent nephrotic syndrome in children", J Korean Soc Pediatr Nephrol, 5, pp.109~116 (2001)
- Bagga A, "Levamisole therapy in corticosteroid-dependent nephrotic syndrome", Pediatr Nephrol, 11, pp.415~417 (1997)
- Neuhaus TJ, "Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome", Arch Dis Child, 71, pp.522~526 (1994)
- Lim HS, "Therapeutic effects of cytotoxic agents (cyclophosphamide and chlorambucil), cyclosporine and levamisole in children with steroid-dependent nephrotic syndrome", Korean J Nephrol, 16, pp.246~253 (1997)
- Dayal U, "Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children", Nephron, 66, pp.408~412 (1994)
- Niaudet P, "Treatment of idiopathic nephrotic syndrome with levamisole", Acta Paediatr Scand, 73, pp.637~641 (1984)
- "Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. british association for paediatric nephrology", Lancet, 337, pp.1555~1557 (1991)
- Montane B, "Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade", Pediatr Nephrol, 18, pp.772~777 (2003)
- Chandra M, "Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil", Pediatr Nephrol, 14, pp.224~226 (2000)
- Bagga A, "Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome", Am J Kidney Dis, 42, pp.1114~1120 (2003)
- Gellermann J, "Frequently relapsing nephrotic syndrome: Treatment with mycophenolate mofetil", Pediatr Nephrol, 19, pp.101~104 (2004)
- Barletta GM, "Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome", Pediatr Nephrol, 18, pp.833~837 (2003)
- Ulinski T, "Switch from cyclosporine A to mycophenolate mofetil in nephrotic children", Pediatr Nephrol, 20, pp.482~485 (2005)
- Zhao M, "Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome", Nephrology (Carlton), 8, pp.105~109 (2003)
- Banerjee S, "Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil", Pediatr Nephrol, 28, pp.93~97 (2013)
- Mendizabal S, "Mycophenolate mofetil in steroid", cyclosporine-dependent, Pediatr Nephrol, pp.2005, 20[DOI]
- Gellermann J, "Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome", J Am Soc Nephrol, 24, pp.1689~1697 (2013)